Canada markets closed

Solasia Pharma K.K. (4597.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
27.00+1.00 (+3.85%)
At close: 03:15PM JST
Currency in JPY

Valuation Measures4

Market Cap (intraday) 4.70B
Enterprise Value 4.03B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.36
Price/Book (mrq)2.51
Enterprise Value/Revenue 6.53
Enterprise Value/EBITDA -6.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-43.48%
S&P500 52-Week Change 323.10%
52 Week High 371.00
52 Week Low 323.00
50-Day Moving Average 332.44
200-Day Moving Average 341.84

Share Statistics

Avg Vol (3 month) 33.18M
Avg Vol (10 day) 33.49M
Shares Outstanding 5173.94M
Implied Shares Outstanding 6180.9M
Float 8140.23M
% Held by Insiders 118.14%
% Held by Institutions 15.26%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -180.23%
Operating Margin (ttm)-2,346.67%

Management Effectiveness

Return on Assets (ttm)-26.55%
Return on Equity (ttm)-49.02%

Income Statement

Revenue (ttm)617M
Revenue Per Share (ttm)3.67
Quarterly Revenue Growth (yoy)-97.50%
Gross Profit (ttm)N/A
EBITDA -639M
Net Income Avi to Common (ttm)-1.11B
Diluted EPS (ttm)-6.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)728M
Total Cash Per Share (mrq)4.18
Total Debt (mrq)60M
Total Debt/Equity (mrq)3.20%
Current Ratio (mrq)3.33
Book Value Per Share (mrq)10.78

Cash Flow Statement

Operating Cash Flow (ttm)-359M
Levered Free Cash Flow (ttm)62.12M